Areva Med DDPU - Plano, TX
Images
Phase I: 8,300 SF R & D Lab / Corporate Offices - Complete
Phase II: TBD
Looking to expand their pharmaceutical research and production to the United States, Areva Med tasked MJMc to design the new DDPU (Domestic Distribution and Purification Unit) facility. This facility will produce high-purity lead-212 and will be used in targeted alpha therapy (TAT) to target cancer cells.
"Targeted alpha therapy (TAT) works by combining the targeting capabilities of cancer cell-specific biological carriers (e.g., antibodies) with the short-range destroying capabilities of the radioactive isotope 212Pb. This approach targets and destroys cancer cells while limiting the impact on nearby healthy cells."
-Areva Med Website
A number of concepts were concieved in the design phase, but due to a tight budget and a design build delivery method, the project was reduced to the 8,300sf facility. The final design consisted of a 50/50 split of lab to office.